STRONG-HF Risk Framework Calculator
Patient parameters
Enter values from the relevant clinical assessment.
About this framework
This page implements a transparent, manually specified points prototype using age, haemodynamics, NT-proBNP, renal function, potassium, LVEF, prior HF hospitalization, and the reported percentage of guideline-directed medical therapy (GDMT) dose achieved at discharge.
It is not an equation derived from the STRONG-HF trial. The variables, point weights, thresholds, and total-score interpretation have not been established as a validated model for predicting an individual's 180-day risk of death or HF readmission.
Prototype scoring rules
| Variable | Rule | Points |
|---|---|---|
| Age | 65–74 years / ≥75 years | +1 / +2 |
| SBP | <100 mmHg | +2 |
| Heart rate | >100 bpm | +1 |
| NT-proBNP | >1000–2000 / >2000–4000 / >4000 pg/mL | +1 / +2 / +3 |
| eGFR | <45 / <30 mL/min/1.73 m² | +1 / +2 |
| Potassium | >5.0 mmol/L | +1 |
| LVEF | <40% | +1 |
| Prior HF hospitalization | Within 12 months | +3 |
| GDMT dose achieved | <50% / 50–<90% | +2 / +1 |
Clinical context
STRONG-HF evaluated a high-intensity care strategy involving rapid GDMT up-titration and close post-discharge follow-up, with monitoring of clinical status, laboratory values, and NT-proBNP. Trial eligibility and protocol safety criteria are not interchangeable with a prognostic score. Medication titration should follow clinical assessment, contraindications, and applicable guideline recommendations.
References
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. The Lancet. 2022;400(10367):1938–1952.
doi:10.1016/S0140-6736(22)02076-1PubMed: 36356631
ClinicalTrials.gov. Safety, Tolerability, and Efficacy of Rapid Optimization, Helped by NT-proBNP Testing of Heart Failure Therapies.
NCT03412201 — official trial recordSafety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial.
PubMed: 37820896Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.